Cerebral nocardiosis in a patient with NHL treated with rituximab [6]

American Journal of Hematology

Volumn 82, Issue 11, 2007, Pages 1033-1034

  Kundranda, Madappa N ^a   Spiro, Timothy P ^a   Muslimani, Alaa ^b   Gopalakrishna, K V ^b   Melaragno, Mark J ^b   Daw, Hamed A ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b FAIRVIEW HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

AGED; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; CRANIOTOMY; DIAGNOSTIC IMAGING; DYSARTHRIA; HEADACHE; HUMAN; IMAGE ANALYSIS; LETTER; MALE; NEUROIMAGING; NOCARDIA BRASILIENSIS; NOCARDIOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEIZURE; STEREOTAXIC SURGERY; SYMPTOM;

AGED; ANTIBODIES, MONOCLONAL; FRONTAL LOBE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, NON-HODGKIN; LYMPHOPENIA; MALE; NOCARDIA INFECTIONS;

EID: 35548961945     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20921     Document Type: Letter

References (5)

1. Czuczman MS, Grillo-Lopez AJ, White CA, et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 1999;17:268-276.
2. Qazilbash MH, Qu Z, Hosing C, et al. Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia. Am J Hematol 2005;80:43-45.
3. Suzan F, Ammor M, Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med 2001;345:1000.
4. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 2000;96:1184-1186.
5. Ravindranath Y. Treatment of refractory immune cytopenias in the 21st century - How safe is rituximab? Am J Hematol 2005;80:92-93.